CNE0000009N6
CNE0000009N6
SINOPHARM ACCORD
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 12.22B EUR | 11.58B EUR | 14.55B EUR | 13.67B EUR |
Enterprise Value | 12.88B EUR | 9B EUR | 13.46B EUR | 10.12B EUR |
Valuation Multiples | ||||
Trailing P/E | 11.41x | 14.75x | 18.09x | 16.18x |
Forward P/E | 7.13x | -- | -- | -- |
Price to Sales | 0.17x | 0.21x | 0.27x | 0.25x |
Price to Book | 0.65x | 0.61x | 0.77x | 0.73x |
EV/Revenue | 0.18x | 0.16x | 0.25x | 0.18x |
EV/EBITDA | 7x | 6.12x | 8.55x | 6.22x |
Price to FCF (P/FCF) | 4.11x | 24.15x | 16.58x | 6.98x |
EV/FCF | 4.33x | 18.77x | 15.35x | 5.17x |
FCF Yield | 24.34% | 4.14% | 6.03% | 14.33% |